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Summary
Aspekty kliniczne NTCP
Streszczenie
Purpose: To review medical literature data on tolerance doses for a number of radiosensitive organs and put forward some proposals of how 
to evaluate a treatment plan in terms of the normal tissue complications or how to estimate it in every-day clinical practice.
Material and methods: Studies assessing the relationship between a dose (dose distribution) and radiation injuries of the heart, liver, lung, 
rectum and parotid gland have been selected for the review.
Results: The Lyman model with Kutcher's reduction algorithm and a relative seriality model proposed by Källman as well as the literature data 
for the heart, liver, lung, rectum and parotid gland are presented. The parameters of the most often used mathematical models describing
the normal tissue complication probability are invoked. The authors' proposals for simple quantitative parameters to be used in clinical 
practice are put forward.
Conclusion: Mathematical radiobiological models should be applied with special caution. Up-to-date three dimensional CT treatment 
planning in radiotherapy makes it possible to collect data for more precise assessment of the relationship between dose and injuries
of sensitive organs.
Key words: injury of normal tissue, radiobiological models, treatment planning.
Cel: Dokonano przegl¹du literatury pod k¹tem danych dotycz¹cych dawek tolerancji dla kilku narz¹dów promieniowra¿liwych. Zapropono-
wano, jak mo¿na w stosunkowo prosty sposób oceniaæ jakoœæ planu leczenia z punktu widzenia dawek zaabsorbowanych przez narz¹dy 
promieniowra¿liwe.
Materia³ i metody: Publikacje naukowe zosta³y przeanalizowane z punktu widzenia zamieszczonych danych opisuj¹cych zale¿noœæ 
pomiêdzy rozk³adem dawki i prawdopodobieñstwem uszkodzenia dla serca, w¹troby, p³uc, rektum i œlinianek przyusznych.
Wyniki: Przedstawiono model radiobiologiczny zaproponowany przez Lymana i Kutchera oraz model opublikowany przez Källmana. 
Przytoczono liczbowe wartoœci parametrów modeli Lymana-Kutchera i Källmana. Zaproponowano proste metody oceny jakoœci planu 
leczenia w oparciu o rozk³ady dawki w narz¹dach promieniowra¿liwych.
Wnioski: Modele radiobiologiczne opisuj¹ce zale¿noœæ dawka-efekt dla narz¹dów promieniowra¿liwych powinny byæ stosowane ze szcze-
góln¹ ostro¿noœci¹. Wspó³czesne przestrzenne systemy planowania leczenia umo¿liwiaj¹ gromadzenie danych, w oparciu, o które mo¿liwe 
jest bardziej precyzyjne okreœlenie zale¿noœci pomiêdzy dawk¹ i prawdopodobieñstwem uszkodzenia narz¹dów promieniowra¿liwych.
S³owa kluczowe: uszkodzenie tkanek zdrowych, modele radiobiologiczne, planowanie leczenia.
Introduction way on the dose and the irradiated volume. Determination
of the relationship between the NTCP as well as the tumour 
The results of many reports have demonstrated that local control probability (TCP) and the dose distribution has been 
control of different malignancies increases with a radiation the subject of many research papers over the past few 
dose. By increasing the prescribed dose, the risk of develo- years. Several mathematical models describing the NTCP 
ping complications to normal structures also become and the tumour control probability (TCP) have been 
greater. For each radiosensitive organ, the normal tissue proposed [1,2,3]. Yet, they, were seldom used for quanti-
complication probability (NTCP) depends in a very complex tative plan evaluation. It is still common practice to evaluate 
and choose the best plan based upon a limited number the fraction volume is equal to V ; (usually V  represents ref ref
of dosimetric endpoints, target dose uniformity and maxi- the whole organ),
mum critical organ doses. This practice generally results m is the slope parameter which affects the steepness
from the lack of reliable mathematical models of TCP and of the S-shaped dose-response curve,
NTCP and the lack of the commercially available treatment n is the parameter which represents the “volume effect”;
planning systems, that enabled us to quantitatively evaluate (n is close to 1 for an organ in which a small volume may
treatment plans. Even if a given model is accepted, the va- be damaged without a significant effect on the function
lues of the parameters used by the model are often put of the whole organ, such organs are referred to as a parallel 
to question. It is difficult to acquire good clinical data that organ; n is close to 0 for an organ in which damaged
may be used for the calculation of these parameters. of a small volume may cause dramatic consequences, such 
However, one may expect that a more common use of CT, organs are referred to as a serial organ).
based 3D treatment planning systems will allow us to deve- For a heterogeneous dose distribution the reduction algo-
lop reliable models of normal tissue response to radiation rithm of the DVH to one step DVH is applied. The influence
or, if the models already proposed are acceptable, to esti- of the fraction dose on the cells' survival is also applied. 
mate more accurately the parameters used in these mo- Instead of the fraction volume, the following equation helps 
dels. to calculate the effective volume:
The purpose of this presentation is to discuss tools
for quantitative evaluation of a treatment plan, especially
for the calculation of the normal tissue complication proba- (5)
bility. Simple parameters describing the quality of a plan will 
be proposed. My presentation is based on a literature re-
view with respect to radiation injury of the rectum, liver, heart, 
lung and salivary glands. (6)
Methods
Dv   is the subvolume of the organ at risk, receiving the total i
Mathematical models for NTCP calculations dose D ,i
D  is the maximum dose absorbed by the organ,max
There are two most often used models: the Lyman model a/b is the parameter of the linear-quadratic model (LQ),
with Kutcher's reduction algorithm and a relative seriality N  is the number of fractions,fr
model proposed by Källman [4,5]. There are three other n is the parameter of relative seriality of the organ/tissue,
models by Fenwick, Jackson: a parallel architecture model d  is the fraction dose of 2 Gy.2Gy
and the Niemierko equivalent uniform dose model [6,7,8]. The basic idea underlying above the model is that if the veff 
The former two ones will be discussed in detail. fraction volume of the organ at risk is irradiated with the dose 
D , the NTCP would be the same as that for the real max
The Lyman model heterogeneous dose distribution. This reduction scheme 
was proposed by Kutcher [4]. 
This model aims at estimating a homogenous dose 
distribution in an organ at risk. Based on this model, the The relative seriality model
NTCP can be expressed by the following equations:
This model of a homogenous dose distribution in the organ 
at risk expresses the NTCP by the following equations [5]:
(1)
              , and (7)
(2)
      (8)
(3)
Dv , D , D , and l  have the same meaning as that in the Ly-i i 50 i
man model.
(4)
g is the slope parameter which has an effect on the steep-
ness of the S-shaped dose-response curves is a parameter 
V  is the volume of the organ, receiving the dose D, of relative seriality of the organ/tissue (serial organ: s = 1, 
TD  is the tolerance dose for 50% of the population when parallel organ s =0).50
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Results lume analysis of the RILD for the largest series of 203 
patients was performed by a group from Ann Arbor [13]. 
Assessment of heart injury Nineteen patients developed of grade 3 or 4 RILD according 
to the Radiation Therapy Oncology Group. For the NTCP 
Close attention has been drawn to heart injury as a con- calculations, the DVH was obtained in the normal liver (liver 
sequence of irradiation when it became clear that the incre- minus gross tumour). The physical dose values were con-
ase in survival in a group of irradiated breast cancer patients verted to normalized iso-biologic effective dose at 1.5 Gy
may be lost because of cardiac mortality due to an exce- /fraction using the LQ model with a/b =2 Gy. The mean do-
ssive dose to the heart [9,10]. In this group of patients, se to the normal liver was also calculated. Using the ma-
the question whether radiation can injure the heart has been ximum likelihood method parameters of the LKB model we-
discussed for many years, because the risk of the adverse re estimated. The calculated value of TD50, m and n being 
effect is relatively small, of the order of several percent, and 43.3 Gy, 0.18 and 1.1, respectively. It should be emphasized 
the injury remains latent for about 15 years. In order to settle that these values are different from the original data publi-
this long-lasting issue a study would be needed in that shed by Burman [14]. The large value of the n parameter 
would include thousands of patients so as to produce suggesst that the liver responds as a typical parallel organ, 
statistically significant results. so a strong correlation between the RILD and the mean liver 
The risk of the excess of late cardiac mortality has usually dose may be expected. It was concluded that below
been calculated with the use of a relative seriality model the mean dose of 30 Gy no patient developed the RILD, and 
[11]. The parameters of the model used by Gagliari are that the NTCP increases approximately by 4% for on incre-
D50=52.4 Gy, g=1.28, s=1. In the paper two organs at risk ment of 1 Gy of the mean dose. The first conclusion is very 
were drawn in CT slices separately: the heart and myo- important for the practice of radiotherapy. When planning
cardium. As the authors stated: “The cranial limit of the heart a treatment, if the treated volume includes parts of the liver, 
included the infundibulum of the right ventricle, the right the biological mean dose should be kept below 30 Gy. It is 
atrium and the right atrium auricule and excluded the pul- worth reminding that in the paper by Dawsan the physical 
monary trunk, the ascending aorta and the superior cava. doses were converted to normalized biological doses
The myocardium was defined with the same external at 1.5 Gy/fraction using a/b =2 Gy [13]. The authors also 
contour as the heart. The wall thickness of the left ventricle confirmed Jackson's results [15]. When the irradiated volu-
was assumed to be between two and three times that me of the liver is kept below the threshold volume, the risk
of the right ventricle. The volume of the myocardium thus of the RILD is estimated as being close to 0 regardless
defined was of the order of about 65% of the heart…” of the dose delivered to this volume. If approximately one-
As usual, physical doses were converted to biologic doses third of the whole liver is irradiated with a dose larger than
by means of a linear-quadratic model with a/b value of 3 Gy. 80 Gy the risk of RILD is negligible.
For typical treatment of breast cancer with two tangential 
beams, with a prescribed dose of 50 Gy, 2 Gy/fraction, Assessment of lung injury
the mean estimated excess of the long-term cardiac 
mortality was about 5%. In another work by Hurkmans For many sites within the chest, the lungs limit the total 
the correlation between the Maximum Heart Distance dose delivered to the target. This problem was seen as par-
(MHD) for a tangential technique and the NTCP was cal- ticularly important for breast patients and for patients under-
culated [12]. The MHD is the maximum distance of the heart going dose escalation protocols for lung cancer. Many 
contour to the medial field end, as can be seen in the beam's papers have been published, but the data substantiating 
eye view (in the simulator radiograph) of the medio-lateral conclusions were questionable. The improvement in ma-
tangential field. For a tangential technique the NTCP values thematical models of photon beams and CT-based treat-
were less than 2% for the MHD smaller than 2 cm. If the MHD ment planning made it possible to obtain a better data col-
exceeds 2 cm the NTCP increases by about 2% for each lection. Some interesting articles concerning this problem 
1 mm increase in the MHD. The results for the dose-volume have been published in the last few years. The early effect 
dependence for the heart injury and the prediction ability associated with radiation energy absorbed by the lungs is 
of models should be treated with high caution. The para- radiation pneumonitis observed over a period of 1-8 months 
meters of these mathematical models were estimated after radiotherapy. The symptoms include fever, dyspnoea, 
on the basis of a small number of mortalities events so cough or even death from respiratory failure. The late sequel 
the error limits are high. is fibrosis appearing 6 months later. Fibrosis causes a re-
duction in pulmonary function. The clinical diagnosis of nor-
Assessment of liver injury mal tissue complications is generally based on whole-organ 
toxicity classified very often according to the Southwest On-
Radiation-induced liver disease (RILD) is a dose-limiting cology Group criteria. Grade 1 (mild) radiation pneumonitis 
complication of liver irradiation. The prospective dose-vo- applies when radiographic changes are observed (diagno-
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sis based on chest X-rays or CT), Grade 2 (moderate) is surement of the influence of the radiation dose on the saliva 
assigned when steroids are required, Grade 3 (severe) secretion is difficult and very time consuming. The relation-
when oxygen is needed, and Grade 4 (life threatening), ship between the 3D dose distributions in the parotid glands 
assisted ventilation is required. The whole-organ toxicity is and the production of saliva was determined in the work
usually mathematically described by means of the Lyman of the group from Ann Arbor [23]. The parotid glands appe-
model or by the relative seriality model. Another approach is ared as a typical parallel organ, for which the mean dose is
to model local changes in function. The cumulative effect a very good predictor of injury. If, the glands receive a mean 
of these changes on both lungs represents a whole-lung dose below 24-26 Gy, a substantial preservation of flow 
change in function. For example, the diffusing capacity rates is observed. If this is the case, a lasting improvement is 
of carbon monoxide is used as an objective index of the pul- observed over time. The authors' data revealed very high 
monary function [16,17,18]. degree of steepness of the NTCP. Glands receiving a mean 
With regard to the problem of lung injury, a methodolo- dose higher than 26 Gy produced little saliva with no reco-
gical question arises, whether to treat both lungs as a single very over time. The parameters of the NTCP Lyman model 
organ or the left and right lung as separate organs. Both were TD50=28.4 Gy, n=1 and m=0.18. These parameters 
answers have their merit, however more often the lungs are were fitted to the clinical data that were converted into binary 
treated as a single organ. In all the recently published pa- values of “severe complications” or “no complications”
pers physical dose distributions were corrected for fractio- for each gland. The authors have defined severe com-
nation, using a linear quadratic model, with an a/b ratio plication as a reduction of stimulated salivary output to less 
of 2.5 - 3.0 Gy. The mean dose to the normal lungs was also than 25% of the pre-radiotherapy output. This is grade
calculated. Using the maximum likelihood method parame- 4 parotid gland toxicity according to the RTOG/EORTC Late 
ters of the LKB model were estimated [19]. The calculated Effects Consensus Conference. Recently, much more pro-
TD50, m and n were 30.8 Gy, 0.37 and 0.99, respectively. mising data for patients irradiated in the head-and-neck 
These values are different from the original data published region were published by Roesnik et al. [24]. Their results 
by Burman. The value of the n parameter of almost 1 sup- confirmed that the parotid gland is a parallel organ. They 
ports the idea that the lungs may be considered as a parallel showed that one year after completion of the treatment
organ. As for the liver, a strong correlation between the ra- the NTCP for the parotid gland is not a very steep curve with 
diation pneumonitis and the mean dose to the lungs was TD50=39 Gy and m=0.45.
observed. If this dose is smaller than about 15 Gy (using nor-
malized biological doses) the incidence of Grade 3 or hig- Assessment of rectum injury
her radiation pneumonitis is near nil. Another single para-
meter may be used as a predictor for the incidence of lung Several papers have dealt with the problem of injury
injury, which is the volume of the lung receiving more than to the rectum and bladder after external beam irradiation. 
the threshold dose. In the paper of Seppenwoolde and Assessment of the adverse effects was mostly based
Gopal, the volume of the lungs receiving a dose exceeding on the RTOG/EORTC or SOMA/LENT scales [24,25]. Late 
13 Gy (using normalized biological dosse) is strongly asso- radiation effects were also assessed by a mailed ques-
ciated with lung injury [20]. In the paper written by Graham tionnaire completed by patients. The NTCP were calculated 
et al., very often cited by other authors, the strongest using the DVHs of the whole rectum including the cavity and 
correlation was found for the volume of lungs received more the rectal wall using the Lyman-Kutcher model and the para-
than 20 Gy [21]. This paper describes the investigation ba- meters published by Burman and his colleagues – n=0.12, 
sed on the physical dose so both results might not differ m=0.15, D50(1)=80 Gy [14,26]. It must be emphasized 
greatly. Gagliari et al. applied the relative seriality model that the parameters apply for endpoints specified as “Seve-
for lungs injury. In her study both lungs were treated as se- re proctitis/necrosis/fistula/stenosis”. Absolute rectal and 
parate organs [17]. The parameters of the model were de- bladder volumes were investigated additionally, irradiated 
termined with the maximum likelihood method. The log like- to various dose levels in correlation with the observed ac-
lihood was even a little higher for this model than for the Ly- tuarial incidence of the gastrointestinal (GI) and genitouri-
man model applied by Seepenwoolde, for which parame- nary (GU) complications. The review of the literature does 
ters were D50=30.1 Gy, g=0.97, s=0.01. not give a clear answer concerning the dose-volume re-
lationship for the rectum and bladder [27,28,29,30,31]. 
Assessment of parotid gland injury There is general agreement that the Lyman-Kutcher model 
with parameters published by Burman does not estimate 
The salivary glands are highly sensitive to radiation [22]. the probability of developing GU and GI complications 
The secretion of the saliva is significantly reduced following reliably. For the bladder it can be explained by a very unre-
10-15 Gy delivered to the largest part of the gland. If the do- liable dose distribution. The bladder volume depends direc-
se is smaller than about 30-40 Gy, some recovery of the fun- tly on the amount of urine it contains. For the rectum it is 
ction of the salivary glands is possible. The precise mea- explained by different endpoints used by Burman and
Kuko³owicz P. NTCP Review paper
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the authors of other articles. In several articles the correla- on radiobiological models should be handled with particular 
tion between late rectal injuries, e.g. bleeding, and the par- caution.
tial volume of the rectum receiving a dose higher then D - VD It must be strongly emphasized that in almost all the latest 
were investigated. Storey et al. found that there is a signi- publications, the physical DVHs are converted to the equi-
ficant increase in late rectal complications when more than valent biological dose (EBD) by means of a linear-quadratic 
25% of rectum received 70 Gy or greater [32]. Very recently model. On one hand there is no doubt that cell survival de-
similar results were obtained by two Italian groups. Cozza- pends on the dose per fraction, so this effect should be 
rini and coworkers showed that the V50 is very predictive accounted for but on the other hand the recalculation
for late bleeding [33]. In their study if V50 is less than 63% of the DVHs to the EBD is an additional source of uncertainty 
there were only 7% of late bleeding (Grade 2-3), if larger than in the NTCP calculations (it is easy to notice that for all nor-
63% the late bleeding increased to more than 25%. Fiorino mal organs the same a/b value is taken into calculations). 
and the others showed that if V50 is less than 60-65% it Another problem is that there is no commercially available 
enables to keep the rate of rectal bleeding (Graden2-3) treatment planning system which enables the EBD calcula-
below 10% [34]. tions. In most cases, however, it is possible to export the da-
TMta to a spread sheet, such as Microsoft Excel , and convert 
Conclusions physical data to biological data.
The lack of reliable, quantitative data on normal tissue 
The NTCP for each organ results from a complex in- pro-bability results mainly from the lack of a precise 3-D do-
teraction between the dose and the irradiated volume. se distribution based on CT calculation and from the lack
Moreover, the probability of injury to a normal tissue may of reliable clinical data. It seems that the first problem is 
depend in each patient on many individual factors. One slowly disappearing due to increased accessibility of CT
should always keep in mind that the uncertainty of the quan- 3-D treatment planning. The other one still remains serious 
titative evaluation of the irradiation risk based on the publi- because of the lack of good clinical practice regarding data 
shed data may be quite high. In clinical practice, it means acquisition. There is an urgent need of a good and precise 
that the quantitative evaluation of the treatment plan based follow up. Simple forms of injury records, based on interna-
Table 1. The tolerance doses (proposals).
organ dose
single quantitative
parameter - tolerance dose
radiobiological model remarks
heart
lung the mean EBD < 15 Gy LKB model
TD50=30.8 Gy, n=0.99,
m=0.37
most often the lung is
treated as a single organ
the volume of the lung
receiving more than
EBD=13 Gy < 30%
liver the mean EBD < 30 Gy LKB model
TD50=43.3 Gy, n=1.1,
m=0.18
NTCP increases of about
4% for 1 Gy increase over
the mean EBD=30 Gy
rectum the physical dose the volume of the rectum
receiving more than
50 Gy < 35-50%,
70 Gy < 25%
there were no reliable data
for any model
the data were acquired
for the treatment with 2 Gy
dose per fraction; many
articles but give inconsistent
conclusions
salivary
glant
the physical dose the mean dose < 30 Gy LKB model
TD50=39 Gy, n=1.0,
m=0.45
only few data in the literature
there is no good single
parameter
for tangential technique the NTCP values were smaller than 2% for the MHD less than 2 cm; if the MHD exceeds 2 cm
than the NTCP increases by about 2% for each 1 mm increase of the MHD
the model should be used
with special caution
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